Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer
Authors:
- Durgatosh Ms PandeyDPDurgatosh Ms Pandey
- Rambha PandeyRPRambha Pandey
- Pankaj Kumar GargPGPankaj Kumar Garg
- 1 April 2017
- journal article
- letter
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 265 (4) , e41-e42
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Lymph Node Retrieval During Esophagectomy With and Without Neoadjuvant ChemoradiotherapyAnnals of Surgery, 2014
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- Comprehensive Registry of Esophageal Cancer in Japan, 2003Esophagus, 2011
- The Roles of Neoadjuvant Radiotherapy and Lymphadenectomy in the Treatment of Esophageal AdenocarcinomaAnnals of Surgical Oncology, 2009
- Modern 5-Year Survival of Resectable Esophageal Adenocarcinoma: Single Institution Experience with 263 PatientsJournal of the American College of Surgeons, 2006
- Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the EsophagusAnnals of Surgery, 2002
- Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique*Diseases of the Esophagus, 2001
- Radical Lymph Node Dissection for Cancer of the Thoracic EsophagusAnnals of Surgery, 1994